For the Inventor, By the Inventor

Enter assignee name

Prometic Biosciences Inc.

USPTO Granted Patents = 30

% Expired Patents = 46.7

CIPO Patents = 10

EPO Patents = 15

Trademarks = 3

Forward Citations = 100

Loading Chart...

Loading Chart...

45 inventors (with patents filed for the assignee):

Christopher L Penney (13 out of 21 patents)

Lyne Gagnon (11 out of 28 patents)

Boulos Zacharie (11 out of 29 patents)

4. Brigitte Grouix (7 out of 19 patents)

5. Jason Richard Betley (6 out of 18 patents)

6. James Christopher Pearson (6 out of 12 patents)

7. Pierre Laurin (5 out of 16 patents)

8. Christopher Robin Lowe (5 out of 32 patents)

9. Lilianne Geerts (4 out of 7 patents)

10. Shaun Abbott (3 out of 10 patents)

11. Jean-François Bienvenu (3 out of 4 patents)

12. Steven James Burton (3 out of 14 patents)

13. Ben Martin Beacom (3 out of 3 patents)

14. Tadeusz Antoni Podgorski (3 out of 3 patents)

15. Helen Rosemary Tatton (3 out of 3 patents)

Core Competencies:

Phenylketone Compounds

Affinity Adsorbents

Cancer Treatment

Medium-Chain Fatty Acids

Triazine Derivatives

Protein Purification

Autoimmune Diseases

Neutrophil Activation

Detoxification Agents

Glycerides

Prion Detection

DNA Separation

30 patents: Sort by Forward Citations

1. 9475750 - Phenylketone carboxylate compounds and pharmaceutical uses thereof (2016-10-25),

2. 9439882 - Compounds and compositions for the treatment of cancer (2016-09-13),

3. 9221768 - Affinity adsorbents for fibrinogen (2015-12-29),

4. 9114118 - Compounds and compositions for the treatment of cancer (2015-08-25),

5. 8946190 - Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer (2015-02-03),

6. 8927765 - Substituted aromatic compounds and pharmaceutical uses thereof (2015-01-06),

7. 8765393 - Endotoxin-binding ligands and their use (2014-07-01),

8. 8637574 - Salts of 3-pentylphenylacetic acid and pharmaceutical uses thereof (2014-01-28),

9. 8551994 - Affinity adsorbents for fibrinogen (2013-10-08),

10. 8501939 - Triazines and pyrimidines as protein binding ligands (2013-08-06),

11. 8487001 - Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors (2013-07-16),

12. 8258295 - Triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivatives (2012-09-04),

13. 8198407 - Sequential protein isolation and purification schemes by affinity chromatography (2012-06-12),

14. 8080555 - Purine derivatives and their use for treatment of autoimmune diseases (2011-12-20),

15. 8076477 - Adsorbents for protein purification (2011-12-13),

Company Overview

Prometic Biosciences Inc., based in Laval, Canada, specializes in the development and manufacturing of innovative biopharmaceutical products. The company focuses on advanced therapies for rare diseases, leveraging its proprietary technologies in protein purification and cell culture. Prometic is dedicated to addressing unmet medical needs through its research in biologics and therapeutic proteins, aiming to improve patient outcomes and enhance the quality of life for individuals affected by challenging health conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

30 Patents

#4 in Laval

#463 in Canada

#21,888 in the World

Prometic Biosciences Inc.

Forward Citations = 100

45 inventors:

Christopher L Penney (13 out of 21 patents)

Lyne Gagnon (11 out of 28 patents)

Boulos Zacharie (11 out of 29 patents)

4. Brigitte Grouix (7 out of 19 patents)

5. Jason Richard Betley (6 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Prometic Biosciences Inc.. Retrieved from https://idiyas.com/company/prometic-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…